120 related articles for article (PubMed ID: 29504731)
1. Expression of matrix metalloproteinase enzymes in endometrium of women with abnormal uterine bleeding.
Grzechocinska B; Dabrowski FA; Chlebus M; Gondek A; Czarzasta K; Michalowski L; Cudnoch-Jedrzejewska A; Wielgos M
Neuro Endocrinol Lett; 2018 Feb; 38(8):537-543. PubMed ID: 29504731
[TBL] [Abstract][Full Text] [Related]
2. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
3. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
Zhang J; Hampton AL; Nie G; Salamonsen LA
Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases-2, -7 and tissue metalloproteinase inhibitor-1 expression in human endometrium.
Grzechocinska B; Dabrowski FA; Cyganek A; Chlebus M; Kobierzycki C; Michalowski L; Gornicka B; Wielgos M
Folia Histochem Cytobiol; 2018; 56(3):133-140. PubMed ID: 30187906
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
6. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Vincent AJ; Zhang J; Ostör A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2002 May; 17(5):1189-98. PubMed ID: 11980737
[TBL] [Abstract][Full Text] [Related]
7. In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.
Rigot V; Marbaix E; Lemoine P; Courtoy PJ; Eeckhout Y
Biochem J; 2001 Aug; 358(Pt 1):275-80. PubMed ID: 11485578
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
Chegini N; Rhoton-Vlasak A; Williams RS
Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
[TBL] [Abstract][Full Text] [Related]
9. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
Luo XH; Liao EY
Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
[TBL] [Abstract][Full Text] [Related]
10. [Expression of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinases-1 mRNA in the endometrium during mid- luteal phase in women with unexplained infertility].
Wu RJ; Zhou FZ
Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):346-9. PubMed ID: 12895377
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
13. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
14. [Anti-inflammatory and hemostatic effects of total extract, saponins, and flavonoids of Clinopodium chinense in female rats with abnormal uterine bleeding and mechanism].
Li LL; Huang Q; Peng DY; Qi JJ; Yao M
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3372-3379. PubMed ID: 35851131
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis.
Szymanowski K; Mikołajczyk M; Wirstlein P; Dera-Szymanowska A
Ann Agric Environ Med; 2016 Dec; 23(4):649-653. PubMed ID: 28030938
[TBL] [Abstract][Full Text] [Related]
17. [Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study].
Bogusiewicz M; Stryjecka-Zimmer M; Rechberger T
Ginekol Pol; 2007 May; 78(5):366-72. PubMed ID: 17867327
[TBL] [Abstract][Full Text] [Related]
18. Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors of MMPs.
Hickey M; Higham J; Sullivan M; Miles L; Fraser IS
Fertil Steril; 2001 Feb; 75(2):288-96. PubMed ID: 11172829
[TBL] [Abstract][Full Text] [Related]
19. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
